US HB2315 | 2013-2014 | 113th Congress
Status
Spectrum: Slight Partisan Bill (Republican 36-18)
Status: Introduced on June 11 2013 - 25% progression, died in committee
Action: 2013-07-25 - Referred to House Energy and Commerce
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 11 2013 - 25% progression, died in committee
Action: 2013-07-25 - Referred to House Energy and Commerce
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Preserving Access to Orphan Drugs Act of 2013 - Amends the Patient Protection and Affordable Care Act (PPACA) to exclude any drug or biological product which is approved or licensed by the Food and Drug Administration (FDA) for marketing solely for one or more rare diseases or conditions (orphan drug) from the annual fee on manufacturers or importers with branded prescription drug sales exceeding $5 million. Makes this Act effective as if included in PPACA.
Title
Preserving Access to Orphan Drugs Act of 2013
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2013-07-25 | House | Referred to House Energy and Commerce |
| 2013-07-25 | House | Referred to House Ways and Means |
| 2013-07-25 | House | Rereferred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2013-06-14 | House | Referred to the Subcommittee on Health. |
| 2013-06-11 | House | Referred to House Ways and Means |
| 2013-06-11 | House | Referred to House Energy and Commerce |
| 2013-06-11 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
Same As/Similar To
SB1128 (Same As) 2013-06-11 - Read twice and referred to the Committee on Finance.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/113th-congress/house-bill/2315/all-info |
| Text | https://www.congress.gov/113/bills/hr2315/BILLS-113hr2315ih.pdf |
